|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 116.4 CHF | +0.82% |
|
+2.83% | -7.32% |
| Mar. 13 | Medacta Group SA Proposes Distribution | CI |
| Mar. 13 | Medacta Group SA Provides Earnings Guidance for the Year 2024 | CI |
Medacta Group SA reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 363.13 million compared to EUR 302.49 million a year ago. Net income was EUR 51.52 million compared to EUR 37.09 million a year ago.
Basic earnings per share from continuing operations was EUR 2.58 compared to EUR 1.85 a year ago. Diluted earnings per share from continuing operations was EUR 2.58 compared to EUR 1.85 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.32% | 2.55B | |
| -4.72% | 182B | |
| +0.05% | 110B | |
| -4.03% | 67.92B | |
| +2.86% | 50.96B | |
| +9.65% | 44.7B | |
| +2.70% | 40.66B | |
| +20.62% | 27.6B | |
| +4.02% | 26.63B | |
| -0.45% | 24.98B |
MEDACTA GROUP SA 
